Recent News

• 26 May 2025   Press Release

  Enamine to Enable Access to Selected Pfizer Reference Compounds to Support the Global Research Community

  Enamine, the leading provider of chemical compounds and drug discovery services, today announced certain reference compounds from Pfizer are now available through Enamine`s marketplace and Enamine`s integration capabilities (i.e. punchout site, hosted catalogs, and API solutions). This allows researchers to explore and purchase from the catalog of selected Pfizer-provided drugs, chemical dormants, investigational compounds, and isotope-labelled molecules with appropriate quality control.

• 21 May 2025   Press Release

  Enamine Establishes Enamine Scientific Research Institute to Accelerate Breakthroughs in Science

  Enamine, the leading provider of chemical compounds and drug discovery services, launches a non-profit organization - Enamine Scientific Research Institute (Enamine SRI). The Institute aims to coordinate scientists in Ukraine supporting research and innovations in chemistry, biology, computer science, and early-stage drug discovery, as well as to help students and young scientists in their development.

• 30 April 2025   Press Release

  Enamine and Pohang Accelerator Laboratory Partner to Speed Up Fragment-Based Discovery Projects

  Enamine, the leading provider of chemical compounds and drug discovery services, and Pohang Accelerator Laboratory (PAL), a science and technology institution in South Korea, have signed a Memorandum of Understanding (MOU) to advance collaborative drug discovery efforts. The memorandum outlines a joint commitment to pursue research and development in fragment-based drug discovery and hit optimization. Both parties aim to provide a streamlined path from fragment identification to advanced leads by combining advanced screening technologies with fast-track chemical development.